CIK 0000719135 · Non-accelerated filer<br>Smaller reporting company
Apyx Medical Corp
Sign in to watch- Ticker
- APYX
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 112644611
- Phone
- 7273842323
- Business address
- 5115 ULMERTON ROAD, CLEARWATER, FL, 33760
- Former names
- BOVIE MEDICAL CORP, BOVIE MEDICAL Corp, AN CON GENETICS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-06-30 | Waldman Lawrence Director | Option exercise | +12,000 | $1.88 | $23K | 17,338 |
| 2026-06-30 | Waldman Lawrence Director | Shares withheld for taxes | −5,024 | $4.49 | $23K | 12,314 |
| 2026-06-30 | Waldman Lawrence Director | Option exercise · Stock option (right to buy) | −12,000 | 0 | ||
| 2026-06-15 | Roman Shawn David Chief Operating Officer | Option exercise | +15,000 | $3.23 | $48K | 15,000 |
| 2026-06-15 | Roman Shawn David Chief Operating Officer | Shares withheld for taxes | −10,533 | $4.60 | $48K | 16,467 |
| 2026-06-15 | Roman Shawn David Chief Operating Officer | Option exercise · Stock option (right to buy) | −15,000 | 0 | ||
| 2026-06-11 | Levine Wendy Lauren Director | Grant or award · Stock Option (Option to Buy) | +50,000 | 50,000 | ||
| 2026-06-11 | Vizirgianakis Stavros G. Director | Grant or award | +450,000 | 2,196,191 | ||
| 2026-06-11 | Goodwin Charles D. II Chief Executive Officer | Grant or award · Stock Option (Option to Buy) | +213,948 | 213,948 | ||
| 2026-06-11 | Roman Shawn David Chief Operating Officer | Grant or award · Stock Option (Option to Buy) | +88,044 | 88,044 | ||
| 2026-06-11 | Baylor-Henry Minnie Director | Grant or award · Stock Option (Option to Buy) | +50,000 | 50,000 | ||
| 2026-06-11 | Waldman Lawrence Director | Grant or award · Stock Option (Option to Buy) | +50,000 | 50,000 | ||
| 2026-06-11 | HILL MATTHEW C Chief Financial Officer | Grant or award · Stock Option (Option to Buy) | +132,066 | 132,066 | ||
| 2026-06-11 | CITRONOWICZ MOSHE Sr. V.P. of Operations | Grant or award · Stock Option (Option to Buy) | +63,392 | 63,392 | ||
| 2026-03-15 | CITRONOWICZ MOSHE Senior Vice President | Option exercise | +37,000 | $1.80 | $67K | 493,504 |
| 2026-03-15 | CITRONOWICZ MOSHE Senior Vice President | Option exercise · Stock option (right to buy) | −37,000 | 0 | ||
| 2026-01-27 | Roman Shawn David Chief Operating Officer | Option exercise | +12,000 | $1.80 | $22K | 12,000 |
| 2026-01-27 | Roman Shawn David Chief Operating Officer | Option exercise · Stock option (right to buy) | −12,000 | 0 | ||
| 2025-05-15 | Waldman Lawrence Director | Grant or award · Stock Option (Option to Buy) | +30,000 | 30,000 | ||
| 2025-05-15 | Vizirgianakis Stavros G. Director | Grant or award · Stock Option (Option to Buy) | +128,000 | 128,000 |
Page 1 of 7 · 131 trades